1906

Microdosed cannabis products for daily wellness

Denver, Colorado, United States

About 1906

1906 specializes in microdosed cannabis products that are designed to fit easily into everyday life. Their products are infused with cannabis and are tailored to promote specific functional experiences such as happiness, energy, relaxation, and brainpower. Each product is created to be straightforward and user-friendly, making cannabis a more trusted and normal part of daily wellness for health-conscious consumers seeking natural alternatives to traditional wellness solutions. Unlike many competitors, 1906 focuses on compliance with federal regulations, ensuring that all products contain hemp-derived Delta 9 THC levels below 0.3%. The company generates revenue through direct sales on their website and partnerships with retail outlets, aiming to provide accessible wellness options for consumers.

Denver, ColoradoHeadquarters
2017Year Founded
$32.5MTotal Funding
LATE_VCCompany Stage
Food & Agriculture, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Parental Leave
Telehealth Options
401(k) Company Match

Risks

Increased competition from companies using advanced data analytics platforms.
Potential regulatory changes could impact cannabis product distribution.
Market saturation in cannabis-infused products could limit growth opportunities.

Differentiation

1906 offers fast-acting cannabis products with effects in 20 minutes.
The company focuses on wellness, not just recreational cannabis use.
1906's products are microdosed for precise, predictable results.

Upsides

Growing consumer interest in microdosing boosts 1906's market appeal.
Cannabis delivery services align with 1906's direct-to-consumer platform.
Older adults seeking natural wellness solutions present a new market for 1906.

Funding

Total raised$32.49 M
Latest valuation$77.00 M
StageLATE_VC
LATE VC
2/28/2022
$15
$77.00 M
EARLY VC
9/30/2019
$18
$90.00 M